These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18453052)

  • 1. [A procedure for calculating needs for antituberculous drugs].
    Bogorodskaia EM; Antonova NV; Perel'man MI; Puchkov KG; Ivanushkina TN
    Probl Tuberk Bolezn Legk; 2008; (3):3-10. PubMed ID: 18453052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New technology of medical service for patients with tuberculosis in outpatient facilities].
    Gavrilenko VS
    Probl Tuberk; 1999; (4):50-2. PubMed ID: 10479939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems in the formation of tuberculosis epidemiological parameters].
    Bogorodskaia EM; Sterlikov SA; Popov SA
    Probl Tuberk Bolezn Legk; 2008; (7):8-14. PubMed ID: 19110764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary drug resistance of Mycobacterium tuberculosis in adolescents with tuberculosis: the specific features of its clinical course, the efficiency of treatment].
    Firsova VA; Poluektova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2008; (5):17-20. PubMed ID: 18711813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF; Ershova NG
    Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
    Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.
    Zvavamwe Z; Ehlers VJ
    Int J Nurs Stud; 2009 Mar; 46(3):302-9. PubMed ID: 18995854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.
    Tabarsi P; Baghaei P; Jalali S; Farnia P; Chitsaz E; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Scand J Infect Dis; 2009; 41(1):10-3. PubMed ID: 19037820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and perspectives of community DOTS].
    Narita T; Kobayashi N
    Kekkaku; 2009 Apr; 84(4):187-201. PubMed ID: 19425394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation.
    Jakubowiak WM; Bogorodskaya EM; Borisov SE; Danilova ID; Lomakina OB; Kourbatova EV
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1210-5. PubMed ID: 17958983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A social backing program and motivation provision in patients with tuberculosis].
    Iakuboviak V; Bogorodskaia EM; Borisov SE; Danilova ID; Lomakina OB; Kurbatova EV
    Probl Tuberk Bolezn Legk; 2009; (3):18-24. PubMed ID: 19459239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
    Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
    Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment support to tuberculous patients--from the standpoint of community support].
    Kekkaku; 2001 Nov; 76(11):707-13. PubMed ID: 11766362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.